Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), an innovative cancer drug discovery and development company, is focused on discovering, developing, and delivering best-in-class medicines designed to treat cancer and related conditions. The company leverages its proven scientific expertise and passion for developing novel small molecule drugs designed to target emerging cancer pathways. Infinity’s two most advanced programs are examples of its innovative approach to oncology drug discovery and development. For further information, visit the Company’s web site at www.infi.com.
- 17 years ago
QualityStocks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI)
Tags Rodman & Renshaw
Related Post
-
MindWave Innovations Inc. (NYSE American: APUS) Is ‘One to Watch’
The company is developing an institutional Digital Asset Treasury model focused on enabling corporations to…
-
American Fusion Inc. (AMFN) Aligns Corporate Identity with Fusion Energy Strategy
American Fusion Inc. has officially changed its corporate name and ticker symbol from Renewal Fuels…
-
Automation Without the Capital Expense: The Economics of RaaS Deployment
TechForce Robotics are advancing automation through a subscription-based RaaSP (Robotics-as-a-Service Provider) The company delivers a…